Top Markets
Coin of the day
Polyrizon Ltd. Polyrizon Ltd.

Polyrizon Ltd.

PLRZ
Rank in Stocks #31772
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of... Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Share Price
$10.81
Last synced: 2026-08-17
Market Cap
$12.11M
Change (1 day)
-1.55%
Change (1 year)
74.92%
Country
IL
Trade Polyrizon Ltd. (PLRZ)

Category

EPS for Polyrizon Ltd. (PLRZ)
EPS as of 2026 TTM: 0
According to Polyrizon Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Polyrizon Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors